StockData

China SXT Pharmaceuticals, Inc. (SXTC) income statement

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$0.11+0.05 (+71.08%)

Close on Oct 19, 2026Market cap –P/E –Yield –

China SXT Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?